Cyclerion Therapeutics CYCN Estimates

NASDAQ CYCN
$3.88 -0.19 (-4.56%)
As of: Aug 21, 2026 · 12:47 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Metric Q1 22Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 711,000.00306,000.00--------
High Estimate 613,568.34371,911.25175,363.470.000.000.000.000.00103,496.59185,812.77
Low Estimate 551,793.66306,215.67148,464.090.000.000.000.000.0091,756.41162,826.63
Consensus Estimate 582,681.00339,063.46161,913.780.000.000.000.000.0097,626.50174,319.70

Quarterly Earnings Per Share (EPS) Estimates

Metric Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q4 25
Reported (Actual) -6.20-------
High Estimate -5.45-5.54-5.41-6.00-5.43-5.54-6.93-0.34
Low Estimate -5.87-6.60-6.59-6.42-5.99-6.38-8.45-0.40
Consensus Estimate -5.66-6.07-6.00-6.21-5.71-5.96-7.69-0.37